Core Laboratories (CLB) Misses Q4 EPS by 16c

Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.21, $0.16 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $138.26 million versus the consensus estimate of $160.5 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Infleqtion raises Q2 revenue to $13.5M after contract restatement